JPMorgan Downgrades Boston Scientific (BSX) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $42.43 -5.84%
Rating Summary:
30 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 18 | New: 18
Rating Summary:
30 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 18 | New: 18
Join SI Premium – FREE
JPMorgan analyst Robbie Marcus downgraded Boston Scientific (NYSE: BSX) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.
Shares of Boston Scientific closed at $45.06 yesterday.
You May Also Be Interested In
- Boston Scientific (BSX) PT Lowered to $44 at Citi
- Roth/MKM Downgrades Enphase Energy (ENPH) to Neutral
- Scotiabank Downgrades Manulife Financial Corp to Sector Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
